Wednesday 17 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Optiobiotix new deal - shares a buy

By HotStockRockets | Saturday 11 July 2015

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Last time we tipped these shares we made 200% plus. So far this time we are a shade down. But that presents a new buying opportunity created by general market weakness.  

Last week OptiBiotix Health (OPTI) announced an agreement with the Spanish National Research Council’s Instituto de Química Orgánica General, “an international renowned centre in the synthesis, analysis, and the study of the biological behaviour of organic compounds in humans”

With OptiBiotix noting that “the last few months have seen substantial progress in reducing the technical risks associated with this exciting programme designed to create low calorie, sweet oligosaccharides” (carbohydrates that consists of a small number of sugars), the agreement contracts IQOG to scale up and purify oligosaccharides for laboratory testing and then assess for organoleptic (taste, texture, aftertaste) and microbiome modulating properties.

The potential of this further development agreement from the company  is further validated by noted recognition from international commercial partners – with the work to include strains from such partners, subject to finalisation of commercial terms.

We continue to believe that, working in a very topical space, as development programmes progress further significant partner interest can be expected. A stock overhang has hindered the share price in recent months but looks to now have been cleared and with the shares having slipped below 35p (a sub £26 million market cap), we view this as an opportunity and continue to target 47p as further operational developments are announced. 

There will be more news on commercialisation very soon and the shares are a buy.

This material first appeared on Hot Stock Rockets. Hot Stock Rockets will be serving up its next red hot share tip shortly. To access the UK’s fastest growing share tipping website for less than £5 a month ( or for £5 for one month)   click HERE

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on OPTI



  1. Its all in the price for now ………..until they get a product nearer to market or a bid.

Enter your comment below. Fields marked * are required. You must preview your comment first before finally posting.

Site by Everywhen